Quantitative analysis of human lung infection treatments caused by Aspergillus fumigatus

Invasive pulmonary aspergillosis (IPA) poses a critical risk for immunocompromised individuals, such as those receiving hematopoietic stem cells or organ transplants. Dynamic42 GmbH models Aspergillus fumigatus (A. fumigatus) fungal invasion in the human lung alveolus using invasive aspergillosis on chip (IAC). Discover how this immunocompetent model offers a complex representation of lung tissue structure and function, providing a reliable platform for antifungal drug development and improving our understanding of fungal pathogenicity.